WO2008093530A1 - 大腸癌病期検出方法 - Google Patents

大腸癌病期検出方法 Download PDF

Info

Publication number
WO2008093530A1
WO2008093530A1 PCT/JP2008/050327 JP2008050327W WO2008093530A1 WO 2008093530 A1 WO2008093530 A1 WO 2008093530A1 JP 2008050327 W JP2008050327 W JP 2008050327W WO 2008093530 A1 WO2008093530 A1 WO 2008093530A1
Authority
WO
WIPO (PCT)
Prior art keywords
clinical stage
colorectal cancer
cdna
cox
detecting
Prior art date
Application number
PCT/JP2008/050327
Other languages
English (en)
French (fr)
Inventor
Shigeru Kanaoka
Original Assignee
National University Corporation, Hamamatsu University School Of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National University Corporation, Hamamatsu University School Of Medicine filed Critical National University Corporation, Hamamatsu University School Of Medicine
Priority to JP2008556040A priority Critical patent/JPWO2008093530A1/ja
Publication of WO2008093530A1 publication Critical patent/WO2008093530A1/ja

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

 大腸癌の病期の診断のためのCOX-2の検出方法、及びCOX-2を含む大腸癌の病期の診断用キットの提供。  工程:a)糞便を採取し、凍結する工程、b)凍結した糞便をRNA分解酵素阻害剤の存在下で均質化し、懸濁物を調製する工程、c)得られたRNAを抽出するための試料から、RNAを抽出する工程、d)抽出されたRNAを逆転写し、cDNAを得る工程、e)得られたcDNAを増幅する工程、f)増幅されたcDNAを検出する工程、g)検出されたcDNA量を定量する工程及びh)得られたcDNA量が大腸癌のいずれの病期に属するかを決定する工程を含む、大腸癌の病期の診断のためのCOX-2の検出方法。
PCT/JP2008/050327 2007-01-30 2008-01-15 大腸癌病期検出方法 WO2008093530A1 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2008556040A JPWO2008093530A1 (ja) 2007-01-30 2008-01-15 大腸癌病期検出方法

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007019235 2007-01-30
JP2007-019235 2007-01-30

Publications (1)

Publication Number Publication Date
WO2008093530A1 true WO2008093530A1 (ja) 2008-08-07

Family

ID=39673844

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/050327 WO2008093530A1 (ja) 2007-01-30 2008-01-15 大腸癌病期検出方法

Country Status (2)

Country Link
JP (1) JPWO2008093530A1 (ja)
WO (1) WO2008093530A1 (ja)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11479824B2 (en) 2018-06-01 2022-10-25 Geneoscopy, Inc. Detection method for cancer using RNA biomarkers
US11479820B2 (en) 2016-10-27 2022-10-25 Geneoscopy, Inc. Detection method using eukaryotic cells

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004083856A1 (ja) * 2003-03-19 2004-09-30 Hamamatsu Foundation For Science And Technology Promotion 大腸癌マーカー検出方法

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004083856A1 (ja) * 2003-03-19 2004-09-30 Hamamatsu Foundation For Science And Technology Promotion 大腸癌マーカー検出方法

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11479820B2 (en) 2016-10-27 2022-10-25 Geneoscopy, Inc. Detection method using eukaryotic cells
US11479824B2 (en) 2018-06-01 2022-10-25 Geneoscopy, Inc. Detection method for cancer using RNA biomarkers

Also Published As

Publication number Publication date
JPWO2008093530A1 (ja) 2010-05-20

Similar Documents

Publication Publication Date Title
WO2009017878A3 (en) High specificity and high sensitivity detection based on steric hindrance & enzyme-related signal amplification
MX2012001000A (es) Metodo y kit para la deteccion de un microorganismo.
WO2007058898A3 (en) Detection of nucleic acids through amplification of surrogate nucleic acids
WO2006063065A3 (en) Detection of nucleic acids from multiple types of human papillomaviruses
WO2008154098A3 (en) Reagents and methods for mirna expression analysis and identification of cancer biomarkers
WO2010053587A3 (en) Methods of monitoring conditions by sequence analysis
WO2008002882A3 (en) Device and method for extraction and analysis of nucleic acids from biological samples
WO2009024691A3 (fr) Procede de dosage du leucocyte elastase inhibitor pour le diagnostic in vitro du cancer colorectal
WO2007089911A3 (en) Methods for detection of circulating tumor cells and methods of diagnosis of cancer in a mammalian subject
WO2010033371A3 (en) Molecular markers for lung and colorectal carcinomas
WO2011160015A3 (en) Rotors for immunoassays
WO2009057294A1 (ja) 肝臓癌関連遺伝子、及び肝臓癌リスクの判定方法
MX2012002411A (es) Metodos de ensayo para el mdv-1.
WO2008155549A3 (en) Improved urine sample collecting and processing
WO2008018859A3 (en) Diagnostic kit for determining genotypes of a human papilloma virus and method of using thereof
WO2010034794A3 (en) Methods and kits for the diagnosis and the staging of colorectal cancer
FR2900936B1 (fr) Procede et methodes de detection de la maladie d'alzheimer
WO2008019006A3 (en) Serum dna methylation screening for cancer
WO2009057829A3 (en) Nucleic acid primer set for detection of drug-resistant strain of hepatitis b virus, assay kit, and method of detecting drug-resistant strain of hepatitis b virus
WO2009019370A3 (fr) Procede de dosage de l'apolipoproteine aii pour le diagnostic in vitro du cancer colorectal
WO2008155891A1 (ja) 新規な動脈硬化性疾患マーカー
WO2012051622A3 (en) Microvesicle-based assays
WO2008093530A1 (ja) 大腸癌病期検出方法
WO2008116178A8 (en) Systems and methods for diagnosis and prognosis of colorectal cancer
CA2518933A1 (en) Method of detecting colon cancer marker

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08703191

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2008556040

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08703191

Country of ref document: EP

Kind code of ref document: A1